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Among the long-term effects of the Chornobyl disaster the greatest concern of international medical and scientific community 
is given to the established fact of excess of the spontaneous level of cancer incidence in the exposed population. According to mo-
dern concepts, the accumulation of chromosome aberrations, especially in radiosensitive cells, could be potentially oncogenic, and 
low doses of ionizing radiation could be promoters of the radiation-induced carcinogenesis. The results of our studies have shown 
that such substances as thymalin, inosine, ascorbic acid, caffeine could modify radiation-induced cytogenetic effects in peripheral 
blood lymphocytes of healthy individuals and exert protective or sensitizing action dependent on their concentrations, cell radio-
sensitivity, dose of irradiation, and relative biologic effectiveness of ionizing radiation. This article is part of a Special Issue entitled 
“The Chornobyl Nuclear Accident: Thirty Years After”.
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�� years ago the glo�al accident at the Chorno�yl 
nuclear power plant has caused long-lasting eco-
logical pro�lems over vast areas of Ukraine� Russia 
and Belarus. According to the official figures� cur-
rently there are a�out �� mln permanent residents 
on the territories of these countries with radionuclide 
contamination; tens of thousands of people work 
in the ��-km Chorno�yl exclusion zone� at nuclear 
power plant in the conditions of increased radiation 
ha zard [�]. There is an increase of the likelihood of hu-
man exposure to ionizing radiation �IR� in low doses� 
which causes stochastic effects� including carcino-
genic ones. At present time� special attention should 
�e given to the transuranic elements �metasta�le 
radionuclides� the negative impact of which on the 
health of population will enlarge in even more remote 
post-Chorno�yl period.
IR �elongs to the most powerful immunosuppres-
sants and carcinogens capa�le to exert neoplastic 
potential at all stages of tumorigenesis. IR can induce 
the appearance of new tumors and accelerate the 
development of already existing neoplasms initially 
not related to irradiation [�]� therefore the Chorno�yl 
disaster is considered to cause enhanced carcino-
genesis [�]. The doses lower than �.�� Gy� which are 
slightly higher than the levels of �ackground radiation� 
could cause malignant transformation of cells [4]. One 
of the main paradigms of radio�iology is the reasoned 
division of the �iological effects of radiation into sto-
chastic or non-stochastic. The latter were officially 
named as “deterministic” and could �e o�served if the 
damage to functioning cells is significant.
Stochastic effects of IR are characterized �y a linear 
non-threshold dependence of the pro�a�ility of their 
occurrence on the IR dose. At the same time� only the 
frequency of analysed events depends on the dose 
of IR� �ut not their severity. This means that even the 
most minimal radiation exposure increases the likeli-
hood of stochastic effects. These are� in fact� the ef-
fects of low dose IR [5�7]. Stochastic effects include 
chromosomal a�errations� point mutations� malignant 
transformation of cells� and the radio�iological reac-
tions without a dose threshold. If deterministic effects 
of the Chorno�yl disaster �general somatic diseases� 
are implemented up to the level of decompensation 
of �5-year post-accident period� stochastic effects 
would not have any limitation period [�].
Several radio�iological studies have shown that 
exposure to low doses induces genomic insta�ility� 
gene mutations� chromosomal a�errations� the for-
mation of reactive oxygen forms� decrease �adaptive 
response� or increase in sensitivity to su�sequent mu-
tagenic effects� repair stimulation� “�ystander” effect� 
the damage of mem�ranes under the influence of free 
radicals �Petkau effect�� and other effects. It should 
�e emphasized that the com�ined effect of mutagenic 
and carcinogenic agents of radiation and chemical 
nature at low doses on the human �ody is almost 
inevita�le. As a result of this com�ination� irradiation 
at low doses can �e particularly dangerous �ecause 
it modifies many reactions of the human organism.
Among the long-term effects of the Chorno�yl di-
saster the greatest concern of the international medi-
cal and scientific community is given to the esta�lished 
fact of excess of the spontaneous level of cancer 
incidence in the exposed population. In recent years� 
the de�ate has intensified a�out the development 
of stochastic effects — radiation carcinogenesis — 
in the range of action of low doses. The issue of dose 
dependence of the radiogenic cancer occurrence 
is an extremely complex and relevant. A paper [�] pro-
vides the details on the radiation-epidemiological data 
o�tained from a representative sample of Chorno�yl 
liquidators� which indicate that “low-dose a�sor�ed 
IR is a statistically significant cancer risk factor”. This 
concept has supporters [�����]. Although the oppo-
site point of view� i.e. the positive effect of IR on the 
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human �ody is also supported. Researchers have even 
recommended that “chronic exposure can �e used for 
cancer prevention” [�����].
The pro�lem of radiogenic cancer largely lies 
in understanding the mechanisms of action of low 
dose IR on the genome� tissues� organs and organism 
as a whole. Careful attention to this pro�lem is due 
to the following issues. Firstly� the effects of low dose 
IR are the promoters of carcinogenesis. Secondly� 
the radiation effect on oncogenesis at low dose range 
may �e greater per unit dose as compared to the ef-
fects of large doses. This is explained �y the fact that 
in the first case the cell death is less pronounced and� 
therefore� the reparative processes are not stimulated 
�y the cell death; induced genomic insta�ility alters the 
sensitivity of the irradiated cells to the action of other 
damaging factors.
Accounting the aforementioned� it is impor-
tant to focus the attention of specialists in the field 
of radio�iology and experimental oncology� not only 
on the characteristics and mechanisms of formation 
of medical and �iological effects of low dose IR� �ut 
also on their modification �y the agents of chemical 
nature. Taking into account the radioecological crisis 
in the post-Chorno�yl period� it is important to focus 
on the search for the ways to protect people from 
chronic exposure to low intensity radiation.
We have developed and proposed a new classifica-
tion of radioprotective drugs with the “modernization 
of the relevant terminology and differentiation of key 
definitions of the mechanisms of radioprotective 
agents” [�7]:
•	radioprotectors (chemical protection) — anti-
radiation drugs that exert a protective effect at the 
physico-chemical and �iochemical level� prevent-
ing the “oxygen effect” as radio�iological phenom-
enon of a�sorption of IR energy during radiolysis 
of �NA;
•	radiomitigators — anti-radiation drugs that exert 
their effect at the system level “�y accelerating 
post-radiation recovery of radiosensitive tissues 
through the activation of a num�er of antiinflam-
matory signaling pathways and increased secre-
tion of hematopoietic growth factors� which are 
used from the early period after exposure until the 
development of clinical manifestations of acute 
radiation injury...” [�7]. The highest activity of the 
drugs of this group appears almost exclusively du-
ring radiation injury of the hematopoietic system. 
Radiomitigators include steroid hormones and 
their non-steroidal structure analogues; adjuvants 
of immunological responses �vaccines� endotoxins� 
polysaccharides� polynucleotides� etc.�; cytokines 
�tumor necrosis factor� growth factors� interferons� 
etc.�; immunoregulatory peptides �thymalin� thy-
mogen� taktivin� timoptin� etc.�. The mechanism 
of radioprotective effect of these compounds 
is related to their a�ility to accelerate the post-
radiation regeneration of the cells of hematopoietic 
system [�����];
•	radiomodulators (biological protection) — 
pharmaceutical su�stances and food supplements� 
which increase the �ody’s resistance to adverse en-
vironmental factors� including IR [��]. This is a large 
group of natural compounds with antioxidant� an-
timutagenic� and antiinflammatory activities [��]. 
The mechanism of their action is characterized 
�y an increase of general �nonspecific� resistance 
of the organism with a decrease of cancer risk [��].
Recently� the research of radio�iologists has �eing 
focused on radioprotective action of cytokines that 
regulate the growth� differentiation� functional activity 
and radioresistance of cells [�4]. The protective effect 
of cytokines is determined �y their hemodynamic 
and immune stimulatory activity as well as their a�i-
lity to increase the endogenous �ackground of ra-
dioresistance� enhancing antitumor response [�5]. 
The organic selenium compounds �for example� 
selenotetracysteine� are recognized as prospective 
means for prevention of radiation injuries� due to the 
low toxicity [��]. The antioxidant mechanism of their 
action is a common characteristic to the formation 
of all �iological effects of selenium and is carried out 
�y selenium containing proteins [�7� ��]. Currently� the 
purine compounds �xanthosine� caffeine� inosine� are 
considered as prospective preventive agents to reduce 
the radiation-related risks [��]. It is shown that the 
efficiency of repair processes �y purine compounds 
is associated with the activation of the poly�A�P-
ri�ose�polymerase — one of the key enzymes in �NA 
repair [��].
The following are the results of our research car-
ried out at the chromosomal level on human peri pheral 
�lood lymphocytes �PBL� — �iological indicators 
of irradiation. Our studies were aimed on clarifying 
the nature of the modifying �enhancement/attenu-
ation� effects of low dose IR in order to improve the 
radioresistance of the human genome.
Thymalin. A study of the effect of radiomitigator 
thymalin [�7] on the radiosensitivity of PBL chromo-
somes of healthy people is required for overcoming the 
negative impact of the Chorno�yl accident. Thymalin 
is a complex mixture of peptides isolated from mam-
malian thymus. It �elongs to the drugs that increase 
the sta�ility of genome and stimulate the immune and 
reparative systems [��]. According to the cytogenetic 
data� � h preincu�ation of T lymphocytes from pe-
ripheral �lood of apparently healthy individuals with 
thymalin demonstrated a radioprotective effect of the 
drug. In particular� thymalin at prophylactic concentra-
tion ��.��� mg/ml of �lood� decrease the frequency 
of chromosomal a�errations upon irradiation at a dose 
of �.� Gy from 5.� ± �.� to �.� ± �.� per ��� cells� and 
at a dose of �.5 Gy �y �-fold — from �.� ± �.� to 4.� ± 
�.�. We supposed that the o�served radioprotective 
effect of thymalin could �e related to its stimulating 
effect on the primary repair of radiation-induced da-
mage. This cytogenetic data allows us to recommend 
thymalin for the persons at the increased carcinogenic 
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risk� especially those exposed to radiation after Chor-
no�yl accident.
Inosine. Purine nucleoside inosine is a drug 
of natural origin used in cardiac practice as a stimulant 
of meta�olic processes� a precursor of the synthesis 
of adenosine triphosphate and nucleotides that sup-
ports energy �alance in various tissues [��]. There are 
esta�lished hemostimulating [��]� immunotropic [�4]� 
antitumor [�5]� and antioxidant activities [��] of this 
drug as well as its a�ility to stimulate the enzymatic 
repair of radiation-induced �NA damage [��]. It is as-
sumed that the effect of inosine on repair processes 
in irradiated cells prevents the formation of intra- and 
interchromosomal rearrangements. It can �e con-
cluded that inosine exerts multifaceted action in a wide 
range of �iological activities� including improving 
overall radioresistance.
We have found that the level of spontaneous chro-
mosomal a�errations in PBL of healthy individuals was 
�.�/��� metaphases �mean population level�� and 
under the influence of inosine administered at a thera-
peutic concentration ��.�� mg/ml of �lood� was 
�.�/��� metaphases� i.e. this agent decreased the fre-
quency of spontaneous a�errations �y �.� times. Also� 
inosine decreased the level of chromatid a�errations 
�y �.7 times� and caused the “disappearance” of the 
chromosomal rearrangement. The introduction of ino-
sine in the therapeutic concentration in the cultures 
of PBL from healthy individuals �efore γ-irradiation 
reduced the incidence of radiation-induced a�erra-
tions over the entire dose range ��.���.� Gy�. The 
highest radioprotective effect of inosine was o�served 
when the cell culture was irradiated at low doses 
of �.���.���.� Gy. The level of radiation-induced 
chromosomal a�errations decreased from �.�� ± �.�; 
7.�� ± �.�; 7.7� ± �.� to �.� ± �.�; �.� ± �.4; �.� ± 
�.�� respectively� thus reaching the values  of average 
population level of spontaneous genetic damage in ra-
diosensitive human T-lymphocytes. Therefore� inosine 
has an antimutagenic and radioprotective effects 
during the irradiation of non-malignant radiosensitive 
cells at low dose range ��.���.���.5 Gy�� reducing the 
level of radiation-induced damage to the spontaneous 
genetic values� there�y increasing the resistance of the 
human genome.
A significant danger is created �y the compounds 
that increase the radiosensitivity of human genome� 
especially �y irradiation at low doses. These include 
co-mutagens� whose effect on the irradiated cells 
remains scarcely analyzed. Therefore� we studied 
in detail the effect of the potential co-mutagen ascor-
�ic acid �AA� on the radiosensitivity of chromosomes 
of human PBL.
Ascorbic acid. The most common antioxidants 
include AA� which is designated as the “signal mol-
ecule that causes specific activity in cells” [�7]. 
Several stu dies have revealed the am�iguous nature 
of AA action in human cells. It is found that� unlike the 
animals� human organism does not produce AA and 
its nutritional deficiency promotes most cancers 
of the stomach� esophagus� oral cavity� and cervix 
[��]. No�el Prize winner L. Pauling proposed the idea 
of  prevention and treatment of neoplasia with high 
doses of AA ��� g per day�. The encouraging results 
were o�tained� �ut the general effect of clinical test-
ing in the most cases turned out to �e misleading 
or even a�sent. Research efforts �y increasing the 
dose up to ��� g AA per day did not cause intoxication� 
�ut had no result either [��]. There is a contrary view� 
according to which vitamins� including AA� are inap-
propriate to use as a prophylactic measure to reduce 
cancer risk [4�]. The data on antimutagenic properties 
of AA are not always confirmed� even in methodologi-
cally similar studies.
We have studied the features of the modification 
of radiation-induced cytogenetic effects in cultured hu-
man PBL under the influence of a potential co-mutagen 
AA [4�]. It has �een shown that at a range of concentra-
tions from ��.� to ��.� g/ml AA did not affect the level 
of spontaneous chromosomal a�errations in lympho-
cytes of donors� which corresponded to mean popula-
tion values ��.� ± �.��/��� metaphases�. The results are 
consistent with the data on the a�sence of the effects 
of antioxidant vitamins on the spontaneous mutation 
level in human lymphocytes [4�].
Analysis of the frequency of chromosomal damage 
induced �y irradiation of PBL in G�-phase of cell cycle 
�at a dose range of �.���.� Gy� with or without post- 
irradiation exposure to AA at therapeutic concentra-
tions of ��.� µg/ml of �lood showed that radiomodify-
ing effect of the drug is not clear. When com�ined with 
the low dose X-ray exposure ��.� Gy�� AA at therapeutic 
concentrations of ��.� µg/ml of �lood caused �.5-fold 
decrease of the total frequency of chromosomal a�er-
rations compared to the effect of irradiation only. This 
is consistent with the findings of the study [4�] showing 
that AA at therapeutic doses exhi�its radioprotective 
activity �y utilizing free radicals and improves the 
antioxidant status of the cells. When irradiating PBL 
at a relatively high dose ��.� Gy� under the influence 
of AA at the same therapeutic concentration� we have 
detected a radiation-potentiating effect� i.e. nearly 
�.4-fold increased total frequency of chromosomal 
a�errations� indicating the co-mutagenic properties 
of the drug. The o�served enhancement of radiation-
induced cytogenetic effect is due to dicentric chro-
mosome formation. Since the formation of dicentrics 
requires local dou�le chromosome �reaks resulting 
from irradiation� the increased yield of a�errations 
of this type under the additional action of AA can 
�e interpreted as a proof of the strengthening of the 
primary radiation damage under the influence of the 
studied drug. These effects can identify the pro�lem 
of clastogenic action of AA on the human genome [44].
Special attention is given to the modification of cy-
togenetic effects of low dose IR �y AA at concentra-
tions exceeding the therapeutic range. It was found 
that an additional post-irradiation effect of AA at the 
doses 4�.����.� µg/ml of �lood increased the overall 
frequency of chromosomal a�errations �y �.� and 
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�.4 times� respectively� when compared to the effect 
of irradiation only at the dose of �.� Gy. It may also 
indicate a co-mutagenic activity of AA� �ut at the 
range of concentrations that exceeds the therapeutic 
value �y � and 4 times. Since the low dose irradiation 
along with chromosomal �reaks can also induce their 
potential pre-mutational changes� the supplementary 
potentiating action of co-mutagens at a high concen-
tration range may contri�ute to their impact into in the 
structural chromosomal rearrangements� including the 
suppression of �NA repair enzymes [45].
Caffeine. According to the study [��]� a purine 
compound caffeine activates the cellular mechanisms 
of post-radiation recovery and �NA repair. The results 
of our study are in disagreement with this conclu-
sion. We have shown that the post-irradiation effect 
of caffeine ���� µg/ml of �lood� during � h increased 
the frequency of chromosomal a�errations in do-
nor’s PBL irradiated in vitro at low doses �y 5.5 times 
as compared with irradiation effect only. This increase 
was due to chromosomal a�errations� mostly paired 
fragments and dicentrics. Caffeine alone had slightly 
increased the spontaneous level of chromosomal 
a�errations. An explanation may �e the following. 
By �locking the entry of cells into the �NA synthesis 
and mitosis� irradiation allows cells to recover from 
radiation-induced damage. Caffeine shortens the 
duration of such �locking� and the cells enter mitosis 
with unrepaired injuries� so the yield of dou�le-strand 
�NA �reaks and chromosomal a�errations increases. 
We o�tained the data at the chromosomal level using 
human somatic cells irradiated at low doses� showing 
the co-mutagenic effect of caffeine. These results are 
in contradiction to the data of study [��]� possi�ly� due 
to the different concentrations of the drug and radia-
tion doses used. Nevertheless� it should �e noted that 
the com�ined action of radiation and chemicals could 
often cause a negative synergistic effect.
CONCLUDING REMARKS
Currently� a lot of attention should �e given to the 
assessment of mutational rate and cancer risk in hu-
man population exposed to low dose IR. This requires 
further study and use of modifiers� selective effects 
of which enhance the radioresistance of the human 
genome and� thus� reduce cancer risk. The prediction 
of modification of low dose IR effects is complicated 
�y a num�er of the following circumstances.
i. It’s necessary to account the individual radio-
sensitivity of the human �ody. If the intensity of the 
radiation exposure is high� the individual characteris-
tics of a person are not of pivotal role� since the volume 
of damage exceeds the protective and compensatory 
capacities of the organism. Therefore� the assessment 
of individual radiosensitivity is particularly important 
at the range of low dose IR responsi�le for the forma-
tion of stochastic effects. Therefore� we recommend 
for the use the chromosomal G�- test modified on the 
�asis of the classic radiation cytogenetics [4�].
ii. The modification of the low dose IR effects 
at the cellular level is weakly dependent on cell-cycle 
phase. This could �e explained �y the fact that under 
the influence of low dose IR� the differences �etween 
the degrees of cell radiosensitivity during cell cycle 
are �alanced.
iii. The modification of low dose IR effects signifi-
cantly depends on the relative �iological effectiveness 
�RBE� of IR. It is known that this varia�le is introduced 
in order to compare the �iological effects of the action 
of various types of radiation at the equal a�sor�ed 
dose. We have found [��] that the largest RBE value 
of densely IR is o�served at low doses. For example� 
the RBE coefficient of fast neutrons in this dosage 
range may reach a value of �� and more. Therefore� 
a targeted modification �enhancement/attenuation� 
of induced effects will �e more pronounced.
iv. The health of the individual should �e taken into 
account. Thus� the progression of tumor growth is as-
sociated with the emergence of new mutational events 
due to the inhi�ition of reparative processes �ecause 
of immunosuppression. Therefore� non-malignant 
cells �e.g. �lood cells� of cancer patients are charac-
terized �y high radiation sensitivity� which affects the 
modification effects of low dose irradiation.
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